je.st
news
Lilly And ImaginAb Announce Preclinical Immuno-Oncology Collaboration
2015-10-14 06:26:33| drugdiscoveryonline News Articles
Eli Lilly and Company (NYSE: LLY) and ImaginAb Inc. are pleased to announce a preclinical research collaboration to study potential novel T-cell-based immuno-oncology therapies.
Tags: collaboration
announce
lilly
preclinical
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|